Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jatinder Dhami"'
Autor:
Cody-Aaron Gathers, Anireddy Reddy, Donald Boyer, Christine Joyce, Nadir Yehya, Neethi Pinto, Margaret Priestley, Adrian Zurca, Jatinder Dhami, Jessica Fowler
Publikováno v:
Critical Care Medicine. 51:281-281
Publikováno v:
Blood. 136:30-30
Von Willebrand disease (vWD) is the most common inherited congenital bleeding disorder. Type 1 is a deficiency, but not absence, of von Willebrand factor (vWF) and is the most common type. Bleeding episodes in patients with type 1 vWD vary and are re
Autor:
Sonia C. Dolfi, Aparna Kareddula, Suzie Chen, Kim M. Hirshfield, Alexei Vazquez, Bhavna S. Paratala, Ashley Rose, Jatinder Dhami, Shridar Ganesan, Gillian M. Mackay, Daniel J. Medina
Publikováno v:
Oncotarget
Recent evidence suggests that glutamate signaling plays an important role in cancer. Riluzole is a glutamate release inhibitor and FDA-approved drug for the treatment of amyotrophic lateral sclerosis. It has been investigated as an inhibitor of cance
Autor:
Jatinder Dhami, Shridar Ganesan, Lorna Rodriguez-Rodriguez, Gregory M. Riedlinger, Julia A. Elvin, Kim M. Hirshfield, Dean Pavlick, Judith K. Amorosa, Veronica Rojas, Mira Hellmann, Hua Zhong, Siraj M. Ali
Publikováno v:
Cold Spring Harbor Molecular Case Studies
FGFR-TACC fusions, including FGFR3-TACC3, have been identified as potential oncogenic drivers and actionable alterations in a number of different cancer types. The clinical relevance of FGFR3-TACC3 fusions in endometrial cancer has not yet been descr